|
|
|
Volumn 1, Issue 1, 2001, Pages 4-
|
|
Aronex Pharmaceuticals reports on annamycin phase I trial.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANNAMYCIN;
ANTINEOPLASTIC ANTIBIOTIC;
DOXORUBICIN;
DRUG DERIVATIVE;
ACUTE DISEASE;
ACUTE LYMPHOCYTIC LEUKEMIA;
ARTICLE;
CLINICAL TRIAL;
DRUG EFFECT;
HEART;
HUMAN;
MYELOID LEUKEMIA;
PHASE 1 CLINICAL TRIAL;
ACUTE DISEASE;
ANTIBIOTICS, ANTINEOPLASTIC;
DOXORUBICIN;
HEART;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE;
LEUKEMIA, MYELOID;
|
|
EID: 0035372452
PISSN: 14737140
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|